Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 11/20 | 0.40 |
| ▸ | CA1 | P00915 | 10/20 | 0.40 |
| ▸ | MMP1 | P03956 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11404267 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL11656430 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL11653580 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL2106475 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL1405391 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL1055310 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL11398170 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL2637496 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| SCHEMBL20657169 | 1.00 | THRB (0.56) | THRBCA2CA1MMP1MMP2 | |
| Ammonia Solution, Strong SCHEMBL10940988 | 0.97 | THRB (0.54) | THRBCA2CA1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111848832-B | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-111892667-B | Application of fluorine-containing compound modified cationic polymer in preparation of medical cosmetic and health care products | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| CN-116845345-A | Preparation method of gel quasi-solid electrolyte, gel quasi-solid electrolyte and lithium ion battery | 阜新德尔汽车部件股份有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-111848831-B | Application of fluorine-containing compound modified cationic polymer in preparation of vaccine medicine | 苏州大学 | 2023-06-13 | — | — | CN | claimed |
| EP-4095162-A1 | APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER | Soochow University (CN) | 2022-11-30 | — | — | EP | claimed |
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | SOOCHOW UNIVERSITY (CN) | 2022-09-01 | — | — | US | claimed |
| WO-2021147585-A1 | USE OF CHITOSAN MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER AND PREPARATION METHOD THEREFOR | 苏州大学 | 2021-07-29 | — | — | WO | claimed |
| WO-2021147598-A1 | APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER | 苏州大学 | 2021-07-29 | — | — | WO | claimed |
| CN-111892667-A | Application of cationic polymer modified by fluorine-containing compound in preparation of medical beauty and health care products | 苏州大学 | 2020-11-06 | — | — | CN | claimed |
| CN-111848832-A | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2020-10-30 | — | — | CN | claimed |
| CN-111848831-A | Application of fluorine-containing compound modified cationic polymer in preparation of vaccine drugs | 苏州大学 | 2020-10-30 | — | — | CN | claimed |
| CN-111848830-A | Application of fluorine-containing compound modified chitosan as drug carrier and preparation method thereof | 苏州大学 | 2020-10-30 | — | — | CN | claimed |
| WO-2020132057-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION (US) | 2020-06-25 | — | — | WO | claimed |
| US-20200203711-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-06-25 | — | — | US | claimed |
| EP-1303258-B1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2006-10-11 | — | — | EP | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| EP-3635022-B1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA TEC LTD (US) | 2025-05-21 | — | — | EP | disclosed |
| US-4255594-A | Hydrogenation of halogen-containing carboxylic anhydrides | ALLIED CHEMICAL CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273806-A1 | USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD | F12, SLCO4C1, SLC7A1 | THRB 1507/4885CA2 748/4885CA1 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.